These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26937750)

  • 1. Surgical Treatment of Metastatic Ovarian Tumors From Extragenital Primary Sites.
    Sal V; Demirkiran F; Topuz S; Kahramanoglu I; Yalcin I; Bese T; Sozen H; Tokgozoglu N; Salihoglu Y; Turan H; Iyibozkurt C; Kolomuc T; Sofiyeva N; Berkman S; Arvas M
    Int J Gynecol Cancer; 2016 May; 26(4):688-96. PubMed ID: 26937750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries.
    Ayhan A; Guvenal T; Salman MC; Ozyuncu O; Sakinci M; Basaran M
    Gynecol Oncol; 2005 Aug; 98(2):235-41. PubMed ID: 15982725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian metastases resection from extragenital primary sites: outcome and prognostic factor analysis of 147 patients.
    Li W; Wang H; Wang J; L V F; Zhu X; Wang Z
    BMC Cancer; 2012 Jul; 12():278. PubMed ID: 22759383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of prognostic factors of 110 patients with metastatic ovarian tumors from gastric cancer].
    Ma Z; Zhang R; Xue Q; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Mar; 19(3):287-91. PubMed ID: 27003649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Value of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer and Application of a Prognostic Score.
    da Costa AA; Valadares CV; Mantoan H; Saito A; Salvadori MM; Guimarães AP; Sanches SM; Achatz MI; Baiocchi G
    Int J Gynecol Cancer; 2016 Mar; 26(3):449-55. PubMed ID: 26825830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors.
    Jiang R; Tang J; Cheng X; Zang RY
    Eur J Surg Oncol; 2009 Jan; 35(1):92-7. PubMed ID: 18632244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of metastatic ovarian tumors from extragenital primary sites.
    Turan T; Aykan B; Koc S; Boran N; Tulunay G; Karacay O; Erdogan Z; Kose F
    Tumori; 2006; 92(6):491-5. PubMed ID: 17260489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical analysis of Krukenberg tumours in patients with colorectal cancer-a review of 57 cases.
    Xu KY; Gao H; Lian ZJ; Ding L; Li M; Gu J
    World J Surg Oncol; 2017 Jan; 15(1):25. PubMed ID: 28088224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian metastases from colorectal cancer: a clinicopathological analysis of 103 patients.
    Kim DD; Park IJ; Kim HC; Yu CS; Kim JC
    Colorectal Dis; 2009 Jan; 11(1):32-8. PubMed ID: 18462217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cytoreductive surgery for non-genital tract metastatic tumors to the ovaries.
    Kim WY; Kim TJ; Kim SE; Lee JW; Lee JH; Kim BG; Bae DS
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):97-101. PubMed ID: 20018420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.
    Luyckx M; Leblanc E; Filleron T; Morice P; Darai E; Classe JM; Ferron G; Stoeckle E; Pomel C; Vinet B; Chereau E; Bergzoll C; Querleu D
    Int J Gynecol Cancer; 2012 Oct; 22(8):1337-43. PubMed ID: 22964527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
    Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
    Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological features and prognosis of 68 patients with metastatic ovarian tumors from the gastric cancer].
    Zhao JZ; Wang G; Zhang RP; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Feb; 13(2):129-32. PubMed ID: 20186624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer.
    Lu LC; Shao YY; Hsu CH; Hsu C; Cheng WF; Lin YL; Cheng AL; Yeh KH
    Anticancer Res; 2012 Aug; 32(8):3397-401. PubMed ID: 22843921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of serum CA(125) level change during chemotherapy post-surgery in patients with advanced epithelial ovarian carcinoma].
    Lan CY; Huang H; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):732-6. PubMed ID: 19087537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
    Chi DS; Eisenhauer EL; Lang J; Huh J; Haddad L; Abu-Rustum NR; Sonoda Y; Levine DA; Hensley M; Barakat RR
    Gynecol Oncol; 2006 Nov; 103(2):559-64. PubMed ID: 16714056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller.
    Chi DS; Barlin JN; Ramirez PT; Levenback CF; Mironov S; Sarasohn DM; Iyer RB; Dao F; Hricak H; Barakat RR
    Int J Gynecol Cancer; 2010 Apr; 20(3):353-7. PubMed ID: 20375796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
    J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.